Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7429)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2022 (publication date) through Dec 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Cao WT, Huang R, Liu S, Fan YH, Xu MS, Xu Y, Ni H. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy. World J Gastroenterol 2022; 28(23): 2582-2596 [PMID: 35949356 DOI: 10.3748/wjg.v28.i23.2582] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Cao WT, Huang R, Liu S, Fan YH, Xu MS, Xu Y, Ni H. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy. World J Gastroenterol 2022; 28(23): 2582-2596 [PMID: 35949356 DOI: 10.3748/wjg.v28.i23.2582] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i23/2582.htm |
| Number | Citing Articles |
| 1 |
Yun Qiu, Shixian Hu, Kang Chao, Lingjie Huang, Zicheng Huang, Ren Mao, Fengyuan Su, Chuhan Zhang, Xiaoqing Lin, Qian Cao, Xiang Gao, Minhu Chen. Developing a Machine-Learning Prediction Model for Infliximab Response in Crohn’s Disease: Integrating Clinical Characteristics and Longitudinal Laboratory Trends. Inflammatory Bowel Diseases 2025; 31(5): 1334 doi: 10.1093/ibd/izae176
|
| 2 |
Junya Song, Huihui Zhang, Huihua Zhang, Ximing Xu, Xiaohua Liang, Yongfang Liu, Xiaomei Song, Hong Guo, Xue Zhan, Jinlin Song, Xiaoqin Zhou. The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective study. Pediatric Discovery 2024; 2(4) doi: 10.1002/pdi3.96
|
| 3 |
Omer Rotem-Tryfus, Ben Kang, Esther Orlanski-Meyer, Oren Ledder, Raffi Lev Tzion, Sujin Choi, Byung-Ho Choe, Youra Kang, Dotan Yogev, Ibrahim Shemasne, Muhammed Shawar, Gili Focht, Dan Turner, Ohad Atia. Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn’s disease: a systematic review and prospective cohort study. Journal of Crohn's and Colitis 2025; 19(10) doi: 10.1093/ecco-jcc/jjaf172
|
| 4 |
Sarah Bencardino, Ferdinando D’Amico, Alessandra Zilli, Tommaso Lorenzo Parigi, Mariangela Allocca, Gionata Fiorino, Silvio Danese, Federica Furfaro. Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases. Journal of Translational Gastroenterology 2024; 2(2): 61 doi: 10.14218/JTG.2024.00017
|